CellBion Statistics

Total Valuation

CellBion has a market cap or net worth of KRW 360.14 billion. The enterprise value is 332.94 billion.

Market Cap	360.14B
Enterprise Value	332.94B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CellBion has 12.82 million shares outstanding.

Current Share Class	12.82M
Shares Outstanding	12.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.45%
Owned by Institutions (%)	3.59%
Float	8.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	140.23
PB Ratio	12.80
P/TBV Ratio	13.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-45.61
EV / Sales	129.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-59.87

Financial Position

The company has a current ratio of 23.82, with a Debt / Equity ratio of 0.09.

Current Ratio	23.82
Quick Ratio	23.30
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-61.87

Financial Efficiency

Return on equity (ROE) is -40.96% and return on invested capital (ROIC) is -22.86%.

Return on Equity (ROE)	-40.96%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-22.86%
Return on Capital Employed (ROCE)	-22.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	23,288.00
200-Day Moving Average	17,695.30
Relative Strength Index (RSI)	62.48
Average Volume (20 Days)	267,917

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellBion had revenue of KRW 2.57 billion and -7.30 billion in losses. Loss per share was -570.21.

Revenue	2.57B
Gross Profit	1.00B
Operating Income	-7.32B
Pretax Income	-7.30B
Net Income	-7.30B
EBITDA	-6.68B
EBIT	-7.32B
Loss Per Share	-570.21

Full Income Statement

Balance Sheet

The company has 29.85 billion in cash and 2.65 billion in debt, giving a net cash position of 27.20 billion or 2,122.01 per share.

Cash & Cash Equivalents	29.85B
Total Debt	2.65B
Net Cash	27.20B
Net Cash Per Share	2,122.01
Equity (Book Value)	28.14B
Book Value Per Share	2,198.56
Working Capital	30.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.35 billion and capital expenditures -210.94 million, giving a free cash flow of -5.56 billion.

Operating Cash Flow	-5.35B
Capital Expenditures	-210.94M
Free Cash Flow	-5.56B
FCF Per Share	-433.94

Full Cash Flow Statement

Margins

Gross margin is 39.04%, with operating and profit margins of -285.19% and -284.22%.

Gross Margin	39.04%
Operating Margin	-285.19%
Pretax Margin	-284.22%
Profit Margin	-284.22%
EBITDA Margin	-260.02%
EBIT Margin	-285.19%
FCF Margin	n/a

Dividends & Yields

CellBion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.03%
FCF Yield	-1.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CellBion has an Altman Z-Score of 19.5 and a Piotroski F-Score of 2.

Altman Z-Score	19.5
Piotroski F-Score	2